Description

A biopsy is a diagnostic procedure where a tissue or cell sample is removed and then examined under a microscope. Biopsies are commonly used to determine whether a tumor or growth is cancerous or non-cancerous (benign). Smart biopsies allow real-time cancer tissue characterization and have been developed and are already being used in some hospitals to accelerate cancer diagnosis. The global smart biopsy devices market is poised to grow by US$ 792.8 million from 2022 to 2028, registering a CAGR of 4.3% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for smart biopsy devices. The global smart biopsy devices market is segmented on the basis of application, and region. By application, the global smart biopsy devices market has been segmented into breast cancer, prostate cancer, skin cancer, liver cancer, others. In terms of geography, the global smart biopsy devices market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America was the largest contributor to the global smart biopsy devices market in 2021.

The global smart biopsy devices market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Argon Medical Devices Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corp., Canon Medical Systems Corporation, Hologic Inc., innoMedicus Ltd., Planmed Oy.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the smart biopsy devices market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Application: breast cancer, prostate cancer, skin cancer, liver cancer, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global smart biopsy devices market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Smart biopsy devices market overview
Part 3. Market breakdown by application
– Breast cancer
– Prostate cancer
– Skin cancer
– Liver cancer
– Others
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 5. Key companies
– Argon Medical Devices, Inc.
– B. Braun Melsungen AG
– Becton, Dickinson and Company
– Boston Scientific Corp.
– Canon Medical Systems Corporation
– Hologic Inc.
– innoMedicus Ltd.
– Planmed Oy
About StrategyHelix
Disclaimer